Medindia

X

Oncology NEWS International Announces More Functional Redesign Aimed at Broader Coverage of the Hematology and Oncology Marketplace

Wednesday, August 6, 2008 General News J E 4
Advertisement
SAN FRANCISCO, Aug. 5 Oncology NEWS International, aleading provider of news and coverage of the hematology and oncology marketfor the past 17 years, has announced a redesign of its editorial content aimedat addressing the ever-changing needs of the cancer care market.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080805/AQTU031)

Effective immediately, readers of Oncology NEWS International will noticea more functional and more appealing format that showcases broader coverageand better represents the readers in the oncology and hematology community.

According to editorial director John Hayes, "The new design caps a seriesof changes we've been making to Oncology NEWS International, all of themintended to keep our readers engaged and better informed about importantdevelopments in the cancer care community. We've preserved the best elementsof our past coverage, particularly clinical trial and study coverage frommeetings and a section devoted to policy and practice, but at the same time wehave expanded our approach to include a more issue-oriented look at theclinical and economic forces that are driving the advancement of hematologyand oncology. "

Steven Rosen, MD, Professor and Director of the Robert H. LurieComprehensive Cancer Center of Northwestern University, serves as the newEditor-in-Chief. "Oncology NEWS International provides the practicingoncologist and hematologist with the latest discoveries that will affect themanagement of our patients. Cancer is a global issue and creating a worldwidedialogue is a critical goal for the publication," says Dr. Rosen, who, alongwith editorial director John Hayes, has introduced several new features to thepublication.

Each month, readers can look forward to:

-- A monthly point-counterpoint feature that examines a topical clinicalcontroversy in cancer care.

-- A monthly profile -- Masters of Hematology and Oncology -- thatexplores the lives of those who have contributed significantly to the field.

-- A greater focus on international developments in hematology andoncology.

-- More analysis and perspective that explains the topical events inhematology and oncology.

-- More attention to the people who are helping shape the practice ofhematology and oncology.

All of these changes serve to position Oncology NEWS International as aleader in bringing oncologists and hematologists global perspectives andanalyses of developments in cancer care.

For more information contact Beatrix Eriksen (Phone: 203-662-6540;Beatrix.Eriksen@cmpmedica.com) or visit Oncology NEWS International online athttp://www.cancernetwork.com.

About The ONCOLOGY Group

For over twenty years, The ONCOLOGY Group has been a leading provider ofinformation addressing the educational needs and interests of cancer careclinicians and patients. The ONCOLOGY Group is comprised of publicationsONCOLOGY, ONCOLOGY Nurse Edition, Oncology NEWS International, The CancerManagement Handbook, as well as the compendium website -- cancernetwork.com.Additionally, The ONCOLOGY Group offers an array of customized projectstailored to address the complex and ever-changing needs of this dynamic field.The ONCOLOGY Group portfolio spans the continuum of cancer care and includes avariety of educational tools for hematology and cancer patients and theircaregivers.

About CMPMedica

CMPMedica, a division of United Business Media plc, provides healthcareinformation and education to primary care physicians, specialists, pharmacistsand patients around the world. Providing journals, magazines, directories,drug databases, other electronic databases, Web sites, face-to-face meetingsand other valuable resources, CMPMedica also delivers comprehensivecommunication solutions for the pharmaceutical and related industries.Employing more than 1,400 people with of
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Noteworthy Medical Systems Acquires MARS Medical S...
S
URAC Board Approves Two New Accreditation Programs...